Gil Ben Cohen
Overview
Explore the profile of Gil Ben Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ben Cohen G, Yaacov A, Ben Zvi Y, Loutati R, Lishinsky N, Landau J, et al.
Comput Biol Med
. 2024 Dec;
185():109491.
PMID: 39700860
Background: The identification and drug targeting of cancer causing (driver) genetic alterations has seen immense improvement in recent years, with many new targeted therapies developed. However, identifying, prioritizing, and treating...
2.
Yaacov A, Ben Cohen G, Landau J, Hope T, Simon I, Rosenberg S
Cell Rep Med
. 2024 Jun;
5(6):101608.
PMID: 38866015
While mutational signatures provide a plethora of prognostic and therapeutic insights, their application in clinical-setting, targeted gene panels is extremely limited. We develop a mutational representation model (which learns and...
3.
Rosenberg S, Ben Cohen G, Kato S, Okamura R, Lippman S, Kurzrock R
Mol Oncol
. 2023 Jan;
17(9):1844-1856.
PMID: 36694946
Genomic analysis, performed on tumoral tissue DNA and on circulating tumor DNA (ctDNA) from blood, is the cornerstone of precision cancer medicine. Herein, we characterized the clinical prognostic implications of...
4.
Landau J, Tsaban L, Yaacov A, Ben Cohen G, Rosenberg S
Cancer Res
. 2022 Oct;
83(1):74-88.
PMID: 36264175
Significance: A new selective advantage estimation assists in oncogenic driver identification and relative effect measurements, enabling better prognostication, therapy selection, and prioritization.